Lehua Shi

2.6k total citations · 1 hit paper
40 papers, 1.8k citations indexed

About

Lehua Shi is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Lehua Shi has authored 40 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hepatology, 17 papers in Surgery and 15 papers in Oncology. Recurrent topics in Lehua Shi's work include Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Lehua Shi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Lehua Shi collaborates with scholars based in China, Hong Kong and United States. Lehua Shi's co-authors include Zhenlin Yan, Mengchao Wu, Feng Shen, Kui Wang, Yong Xia, Jun Li, Dong Wu, Xuying Wan, Renyan Gong and Yizhou Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Lehua Shi

40 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy

2013 839 citations Yizhou Wang, Jun Li et al. profile →

Peers

Countries citing papers authored by Lehua Shi

Since Specialization

Citations

This map shows the geographic impact of Lehua Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lehua Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lehua Shi more than expected).

Fields of papers citing papers by Lehua Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lehua Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lehua Shi. The network helps show where Lehua Shi may publish in the future.

Co-authorship network of co-authors of Lehua Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Lehua Shi. A scholar is included among the top collaborators of Lehua Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lehua Shi. Lehua Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Survival Mechanisms and Influence Factors of Circulating Tumor Cells 2018 ·BioMed Research International ·Wenchao Wang, Xiaofeng Zhang, Jian Peng, Xifeng Li, Aili Wang, (unknown), Lehua Shi, Moubin Lin	80
2	Intrahepatic splenosis mimics hepatocellular carcinoma in a patient with chronic hepatitis B 2017 ·Medicine ·Wenchao Wang, Xifeng Li, Zhenlin Yan, Yu Wang, (unknown), Lehua Shi, Xiaofeng Zhang	10
3	Nomograms for Pre-operative and Post-operative Prediction of Long-Term Survival of Patients Who Underwent Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma 2016 ·Annals of Surgical Oncology ·Qifei Zou, Jun Li, Dong Wu, Zhenlin Yan, Xuying Wan, Kui Wang, Lehua Shi, Wan Yee Lau, Mengchao Wu, Feng Shen	37
4	Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma 2016 ·PLoS ONE ·Jian Liu, Kui Wang, Zhenlin Yan, Yong Xia, Jun Li, Lehua Shi, Qifei Zou, Xuying Wan, Binghua Jiao, Hongyang Wang, Mengchao Wu, Yongjie Zhang, Feng Shen	44
5	Randomized Controlled Trial of Hepatic Portal Reocclusion as a New Option for Detecting Bile Leakage during Hepatic Resection 2016 ·Digestive Surgery ·(unknown), Xifeng Li, (unknown), (unknown), Kui Wang, Yu Wang, Wenchao Wang, (unknown), Feng Shen, Lehua Shi, Xiaofeng Zhang	3
6	Elevated Serum Carcinoembryonic Antigen Is Associated with a Worse Survival Outcome of Patients After Liver Resection for Hepatocellular Carcinoma: a Propensity Score Matching Analysis 2016 ·Journal of Gastrointestinal Surgery ·Jianwei Liu, Yong Xia, Lehua Shi, Xifeng Li, Lu Wu, Zhenlin Yan	3
7	Effectiveness of repeat hepatic resection for patients with recurrent intrahepatic cholangiocarcinoma: Factors associated with long-term outcomes 2016 ·Surgery ·Anfeng Si, Jun Li, (unknown), Zhengqing Lei, Yong Xia, Zhenlin Yan, Kui Wang, Lehua Shi, Feng Shen	37
8	Loss of function of Notch1 identifies a poor prognosis group of early stage hepatocellular carcinoma following hepatectomy 2015 ·Oncology Reports ·Jian Liu, Jingfeng Liu, (unknown), Zhenlin Yan, Xuying Wan, Aimin Huang, Yizhou Wang, Jun Li, Yong Xia, Lehua Shi, Binghua Jiao, Yongjie Zhang, Feng Shen	5
9	Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma 2013 ·BMC Gastroenterology ·Yanming Zhou, Xiaofeng Zhang, Lupeng Wu, Feng Ye, Xu Su, Lehua Shi, Bin Li	32
10	Intratumoral Hepatic Stellate Cells as a Poor Prognostic Marker and a New Treatment Target for Hepatocellular Carcinoma 2013 ·PLoS ONE ·Bin Sun, Xiaofeng Zhang, Xianshuo Cheng, Yu Zhang, Lei Chen, Lehua Shi, Zhenyu Liu, Haihua Qian, Mengchao Wu, Zhengfeng Yin	21
11	Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study. 2012 ·PubMed ·Tao Xi, Eric C. H. Lai, (unknown), Lehua Shi, Dong Wu, Feng Xue, Kui Wang, (unknown), Yong Xia, Feng Shen, Wan Yee Lau, Mengchao Wu	26
12	A Case-Control Study of Correlation between Preoperative Serum AFP and Recurrence of Hepatocellular Carcinoma after Curative Hepatectomy 2012 ·Hepatogastroenterology ·Yong Xia, (unknown), Tao Xi, Kui Wang, Jun Li, Lehua Shi, Meng-Chao Wu, Feng Shen	10
13	Sorafenib down-regulates c-IAP expression post-transcriptionally in hepatic carcinoma cells to suppress apoptosis 2012 ·Biochemical and Biophysical Research Communications ·Xifeng Li, Renyan Gong, Meng Wang, Zhenlin Yan, Bo Yuan, Kui Wang, Lehua Shi	9
14	Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma 2012 ·Hepatology ·Xiong Cai, Jian Zhai, David E. Kaplan, Yijun Zhang, (unknown), Xutao Chen, (unknown), Qiudong Zhao, Yonghai Li, Lu Gao, Wen‐Ming Cong, Ming-hua Zhu, Zhenlin Yan, Lehua Shi, Dong Wu, Lixin Wei, Feng Shen, Mengchao Wu	66
15	Transforming Growth Factor beta1 Gene Variation Leu10Pro Affects Secretion and Function in Hepatic Cells 2012 ·Digestive Diseases and Sciences ·Xing Gu, (unknown), Lehua Shi, (unknown), Yunpeng Zhao, Aihua Wang, Lungen Lu, Wenbo Yu, Chunfang Gao	6
16	Isolation of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Using a Novel Cell Separation Strategy 2011 ·Clinical Cancer Research ·Wen Xu, Lu Cao, Lei Chen, Jing Li, Xiaofeng Zhang, Haihua Qian, Xiaoyan Kang, Yu Zhang, Jian Liao, Lehua Shi, Yefa Yang, Meng-Chao Wu, Zhengfeng Yin	128
17	Lens Culinaris Agglutinin-Reactive Fraction of Alpha-Fetoprotein as a Marker of Prognosis and a Monitor of Recurrence of Hepatocellular Carcinoma After Curative Liver Resection 2011 ·Annals of Surgical Oncology ·Xiaofeng Zhang, Eric C. H. Lai, Xiaoyan Kang, Haihua Qian, Yanming Zhou, Lehua Shi, Feng Shen, Yefa Yang, (unknown), Wan Yee Lau, Mengchao Wu, Zhengfeng Yin	20
18	Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study 2011 ·Hepatobiliary & pancreatic diseases international ·Zhenyu Liu, Yanming Zhou, Lehua Shi, Zhengfeng Yin	35
19	Overexpression of Aspartyl-(Asparaginyl)-β-Hydroxylase in Hepatocellular Carcinoma Is Associated With Worse Surgical Outcome 2010 ·Hepatology ·Kui Wang, Jian Liu, Zhenlin Yan, Jun Li, Lehua Shi, Wen‐Ming Cong, Yong Xia, Qifei Zou, Tao Xi, Feng Shen, Hongyang Wang, Mengchao Wu	93
20	Protective effect of prednisolone on ischemia-induced liver injury in rats 2008 ·World Journal of Gastroenterology ·Meng Wang, Feng Shen, Lehua Shi, Tao Xi, Xifeng Li, Xu Chen, Meng-Chao Wu	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact